These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 7895948
1. Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug. Gross DJ, Sidi H, Weiss L, Kalland T, Rosenmann E, Slavin S. Diabetologia; 1994 Dec; 37(12):1195-201. PubMed ID: 7895948 [Abstract] [Full Text] [Related]
2. Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide). Slavin S, Weiss L, Xia W, Gross DJ. Cell Transplant; 1996 Dec; 5(6):627-30. PubMed ID: 8951220 [Abstract] [Full Text] [Related]
3. Linomide does not prevent spontaneous autoimmune thyroiditis in NOD mice. Hartoft-Nielsen ML, Rasmussen AK, Kaas A, Bock T, Buschard K, Feldt-Rasmussen U. Autoimmunity; 2001 Dec; 33(2):79-84. PubMed ID: 11264786 [Abstract] [Full Text] [Related]
4. Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment. Gross DJ, Weiss L, Reibstein I, van den Brand J, Okamoto H, Clark A, Slavin S. Endocrinology; 1998 May; 139(5):2369-74. PubMed ID: 9564847 [Abstract] [Full Text] [Related]
8. Prevention and treatment of type I diabetes in NOD mice by linomide. Slavin S, Gross D, Weiss L. Transplant Proc; 1995 Dec; 27(6):3240. PubMed ID: 8539933 [No Abstract] [Full Text] [Related]
12. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Christianson SW, Shultz LD, Leiter EH. Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606 [Abstract] [Full Text] [Related]
13. Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice. Saï P, Senecat O, Martignat L, Gouin E. Clin Exp Immunol; 1994 Jul; 97(1):138-45. PubMed ID: 8033411 [Abstract] [Full Text] [Related]
14. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. Qin HY, Sadelain MW, Hitchon C, Lauzon J, Singh B. J Immunol; 1993 Mar 01; 150(5):2072-80. PubMed ID: 8436836 [Abstract] [Full Text] [Related]
17. Linomide, a new treatment for autoimmune diseases: the potential in type 1 diabetes. Slavin S, Sidi H, Weiss L, Rosenman E, Kalland T, Gross D. Diabetes Metab Rev; 1993 Dec 01; 9(4):311-5. PubMed ID: 7924828 [No Abstract] [Full Text] [Related]
18. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice. Chaillous L, Darquy S, Maugendre S, Rivereau AS, Reach G, Saï P. Diabetologia; 1996 May 01; 39(5):523-9. PubMed ID: 8739911 [Abstract] [Full Text] [Related]
19. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy. Qin HY, Elliott JF, Lakey JR, Rajotte RV, Singh B. J Autoimmun; 1998 Dec 01; 11(6):591-601. PubMed ID: 9878081 [Abstract] [Full Text] [Related]
20. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Mellanby RJ, Thomas D, Phillips JM, Cooke A. Immunology; 2007 May 01; 121(1):15-28. PubMed ID: 17428252 [Abstract] [Full Text] [Related] Page: [Next] [New Search]